Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 26:36:102225.
doi: 10.1016/j.ajoc.2024.102225. eCollection 2024 Dec.

A case of treating polypoidal choroidal vasculopathy subretinal fluid by subthreshold micropulse laser

Sarmad Mustafa Jafar  1 , Zaid Rajab Hussein  2 , Muthanna Basheer Yasir  2
Affiliations
Case Reports

A case of treating polypoidal choroidal vasculopathy subretinal fluid by subthreshold micropulse laser

Sarmad Mustafa Jafar et al. Am J Ophthalmol Case Rep. .

Abstract

Purpose: Assess the effectiveness of a subthreshold micropulse laser for treating a patient with polypoidal choroidal vasculopathy and subretinal fluid.

Observations: A 55-year-old female presented with left eye blurring vision and metamorphopsia, and her visual acuity was 20/60. Optical coherence tomography (OCT) and OCT angiography showed subretinal fluid and pigmented epithelium detachment with a small polyp under the retinal pigmented epithelium, which was diagnosed as polypoidal choroidal vasculopathy. She was treated with a subthreshold micropulse (577nm) laser and showed a dramatic response within 12 weeks with the disappearance of subretinal fluid and visual acuity improving to 20/25.

Conclusion and importance: A subthreshold micropulse laser might be an effective and safe option for treating patients with polypoidal choroidal vasculopathy and subretinal fluid.

Keywords: Micropulse laser; Polypoidal choroidal vasculopathy; Subretinal fluid.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Left eye OCT and OCT angiography at presentation. These Show choroidal polyp (Blue arrow), Subretinal fluid (Orange arrow), Choroidal polyp with active flow by OCTA (Green arrow).
Fig. 2
Fig. 2
OCT and OCT angiography of the right eye at presentation, showing normal OCT except small drusen(arrow).
Fig. 3
Fig. 3
Left eye OCT and OCT angiography after 4 weeks of treatment by micropulse, showing decrease of subretinal fluid (white arrow), choroidal polyp (blue arrow).
Fig. 4
Fig. 4
Left eye OCT and OCT angiography after 12 weeks of treatment by micropulse, showing no subretinal fluid (white arrow), choroidal polyp (blue arrow).
Fig. 5
Fig. 5
Left eye OCT and OCT angiography after 24 weeks of treatment by micropulse, showing no subretinal fluid.
See this image and copyright information in PMC

References

    1. Yannuzzi L.A., Sorenson J., Spaide R.F., Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV) Retina. 1990;10:1–8. - PubMed
    1. Imanmura Y., et al. Polypoidal choroidal vasculopathy: a review. Surv Ophthalmol. 2010;55:501–515. - PubMed
    1. Maruko I., Iida T., Saito M., et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol. 2007;144:15–22. - PubMed
    1. Nakashizuka H., Mitsumata M., Okisaka S., et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2008;49:4729–4737. - PubMed
    1. Zhao J., Chandrasekaran P.R., Cheong K.X., Wong M., Teo K. New concepts for the diagnosis of polypoidal choroidal vasculopathy. Diagnostics. 2023;13(10):1680. - PMC - PubMed

Publication types

LinkOut - more resources